Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Kynam Capital Management, LP | 472.4K | $6.0M | 0.11% | +83.1K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 300.5K | $4.0M | 0.07% | +134.3K | 2026-03-31 |
| MORGAN STANLEY | 293.2K | $4.0M | 0.07% | -36.9K | 2026-03-31 |
| Point72 Asset Management, L.P. | 240.8K | $3.0M | 0.06% | +204.3K | 2026-03-31 |
| Waterfront Wealth Inc. | 203.3K | $2.0M | 0.05% | +60.8K | 2026-03-31 |
| Eversept Partners, LP | 147.7K | $2.0M | 0.04% | -24.5K | 2026-03-31 |
| CITADEL ADVISORS LLC | 91.6K | $1.0M | 0.02% | -88.8K | 2026-03-31 |
| BNP PARIBAS FINANCIAL MARKETS | 75.5K | $1.0M | 0.02% | -28.8K | 2026-03-31 |
| LCM Capital Management Inc | 43.5K | -- | 0.01% | +1.2K | 2026-03-31 |
| STATE STREET CORP | 24.9K | -- | 0.01% | +1.1K | 2026-03-31 |
